| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |